sitem-insel AG

Dr. Max Corbett

Senior Director Global CMC Plasma Product Development, CSL Behring


Translational Medicine and Biomedical Entrepreneurship:


Max is the Senior Director, Head of Plasma Product Development CMC at CSL Behring. He manages a global team of CMC Leads responsible for new product development, which includes the definition and execution of (1) CMC packages to enable the phase specific process, analytical, formulation, and product development, (2) regulatory CMC strategy, documentation, & submissions, and (3) clinical manufacture & supply.
Max enjoys combining his experience in product development, manufacturing, quality control, validation, quality assurance, and regulatory affairs to define and execute business and patient appropriate strategies for recombinant, plasma-derived, and cell based therapies throughout the product lifecycle.